Vaccination News Home Page                                            subscribe Vaccination NewsLetter

http://news.bmn.com/magazine/researchupdate?uid=UPDATE.Michie2803200375

 
Journal
Collection
Reviews Research
Update
Research
Tools
News &
Features
Books &
Labware
Science
Jobs
news.bmn.com Latest
Updates
Today's
News
Magazine Conference
Reporter
Commentary Journal
Scan
Special
Report
My E-mail
Alerts
Section
Search
  My BMN My BMN Exit Exit  
  Send Feedback to BMN Feedback Help System Help  


 

About this Section
Research Update
Updated daily, Research Update presents short, easy to read commentary on the latest hot papers, enabling you to keep abreast with advances across the life sciences. Written by laboratory scientists with a keen understanding of their field, Research Update will clarify the significance and future impact of this research.

Articles will be freely available for a promotional period until 31st May 2003.

Our experienced in-house team are under the guidance of a panel of experts from across the life sciences who offer suggestions and advice to ensure that we have high calibre authors and have spotted the 'hot' papers.

Visit the Research Update daily at http://update.bmn.com and sign up for email alerts to make sure you don't miss a thing.


 

 


 
 
Antibody production in early life supported by maternal lymphocyte factors
Shimamura M. et al.
Biochimica et Biophysica Acta (BBA)/Molecular Basis of Disease 2003 1637(1):55-58
MEDLINE   Full Text
28 March 2003
Commentary by Colin Michie colinm@easynet.co.uk 
The ability of mammalian newborns to respond to infection is critical as this is the period of greatest morbidity and mortality from infections. Maternal IgG antibody moves across the placenta and IgA is present in milk, but all de novo antibody production by the young is typically slower than in older members of the species. Work with babies demonstrated many years ago that those who were breast-fed made more effective and rapid antibody responses to vaccination. A recent study has taken this observation further, by examining the effects of feeding mouse pups from mothers with reduced lymphocyte numbers.



 

Litters fed from Rag -/- mothers, who have very few circulating or milk lymphocytes, made lower levels of antibody when compared with those fed from Rag +/+ mothers. Those with Rag +/- mothers showed similar responses to Rag +/+ pups. By exchanging mothers, the antibody responses in the pups could be altered. This observation suggests that milk lymphocytes are indeed a significant component to the neonatal murine immune system. It is not clear whether it is the lymphocytes themselves, or factors they produce, which are necessary, or at which cellular or molecular level the mechanism operates for this adjuvant-like activity. The observation may well link with that made in babies who have been shown to have significantly larger thymus glands if breast-fed.

The Rag mouse model allows other questions to be asked of milk production, the development of mastitis, and therefore milk quality and quantity. Such questions are important in agricultural situations where inflammatory changes are well known to reduce the milk output of domesticated animals. The term 'Rag' is relevant here, not as an eponym for 'Rapid activating gene' but as part of a name, 'Round Oak Rag Apple Elevation', a Holstein cow, had triplets, 26 sisters and 4215 three quarter sisters as a consequence of assisted reproductive technology (VanRaden (1997) J Dairy Sci 75). The lactation records of all these animals have been followed for three generations. This extensive database is beginning to allow careful genetic analysis of milk immunology; it too demonstrates the significance of maternal genetic factors to milk quality and the outcome of the calf consuming that milk.

Such data give a prospect to augmenting existing milks. Might milks be adjusted for the premature so as to enhance antibody responses in those whose trans-placental antibody levels are low? Might these factors allow improvement of the routine vaccination programmes, designed around the poor antibody responses of the infant human? Such prospects offer advantages to those working locally in neonatal nurseries or on a wider scale in public health.



 

Articles will be freely available for a promotional period until 31st March 2003.
 

 
BioMedNet Magazine
23rd April - 6th May 2003
home icon Magazine Home
email icon Email to a Friend
full article icon Printer ready version

 
Further Reading
IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms
Macpherson, A., Hunziker, L., McCoy, K. and Lamarre, A. (2001) Microbes and Infection 12:1021-1035.
Further related articles


BioMedNet
Home
News &
Features
My BMN
 
Help System
 
Send Feedback to BMN
 
Information for Advertisers © Elsevier Limited 2003

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.